Skip to content

    Vir Biotechnology (VIR) stock price & financials

    View VIR earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+107.1% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $2.38M
    $12.37M
    $3.03M
    $1.21M
    $240.0K
    -89.9%
    $64.07M
    +417.8%
    -$29.0K
    -101.0%
    $238.95M
    +19582.5%
    Strengthening
    Operating Profit
    -$231.30M
    -$117.15M
    -$139.55M
    -$118.42M
    -$173.44M
    +25.0%
    -$47.92M
    +59.1%
    -$132.29M
    +5.2%
    $73.47M
    Strengthening
    Net Profit
    -$213.72M
    -$104.59M
    -$120.97M
    -$110.96M
    -$163.14M
    +23.7%
    -$42.92M
    +59.0%
    -$125.69M
    -3.9%
    $80.08M
    Strengthening
    EPS
    $-1.56
    $-0.88
    $-0.80
    $-1.17
    +25.0%
    $-0.85
    +3.4%
    $0.48
    Strengthening
    Other Income
    $17.76M
    $12.47M
    $18.60M
    $7.63M
    $10.47M
    -41.1%
    $4.86M
    -61.0%
    $6.76M
    -63.6%
    $6.79M
    -11.0%
    Weakening
    Interest
    Depreciation
    Profit before Tax
    -$213.54M
    -$104.67M
    -$120.95M
    -$110.79M
    -$162.97M
    +23.7%
    -$43.06M
    +58.9%
    -$125.53M
    -3.8%
    $80.26M
    Strengthening
    MarginsOPM
    -9718.7%
    -946.7%
    -4602.5%
    -9754.3%
    -72267.9%
    -643.6%
    -74.8%
    +92.1%
    456172.4%
    30.8%
    Strengthening
    Tax
    -0.1%
    0.1%
    -0.0%
    -0.1%
    -0.1%
    -25.0%
    0.3%
    +300.0%
    -0.1%
    -1300.0%
    0.2%
    Weakening
    ReturnsROIC
    14.3%
    7.0%
    8.1%
    7.4%
    10.9%
    -23.7%
    2.9%
    -59.0%
    8.4%
    +3.9%
    -5.4%
    -172.2%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$47.60M$109.33M$436.57M$347.81M$848.63M$241.58M$222.95M$232.19M$278.73M
    Short-Term Investments$50.84M$274.10M$300.29M$217.18M$1.52B$1.27B$678.05M$228.75M$249.86M
    Total Current Assets$117.78M$403.00M$772.37M$1.56B$2.52B$1.59B$1.04B$514.08M$573.74M
    Net PP&E$12.29M$16.31M$79.89M$130.05M$188.17M$167.20M$122.86M$117.72M$109.82M
    Goodwill$16.94M$16.94M$16.94M$16.94M$16.94M$16.94M$16.94M$16.94M$16.94M
    Intangibles$36.92M$35.69M$33.82M$33.29M$32.76M$22.57M$8.12M$7.85M$7.70M
    Total Assets$191.60M$512.07M$918.76M$1.95B$2.80B$1.92B$1.40B$1.00B$1.21B
    LiabilitiesTotal Current Liabilities$39.91M$59.21M$99.06M$341.24M$511.03M$175.41M$119.66M$92.81M$94.96M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$66.56M$133.56M$123.84M$111.67M$90.14M$89.05M$84.14M
    Total Liabilities$61.64M$88.13M$201.91M$522.42M$724.13M$328.82M$248.43M$237.55M$232.31M
    EquityCommon Stock & APIC$1.0K$11.0K$13.0K$13.0K$13.0K$13.0K$14.0K$14.0K$17.0K
    Retained Earnings-$193.84M-$368.52M-$667.18M-$138.60M$377.24M-$237.82M-$759.78M-$1.20B-$1.24B
    Total Equity-$179.18M$423.94M$716.85M$1.43B$2.08B$1.59B$1.15B$765.28M$982.49M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$94.10M-$129.63M-$190.94M-$47.59M$1.66B-$778.78M-$446.35M-$391.78M-$202.51M
    Cash from Investing-$60.44M-$256.16M-$9.86M-$140.81M-$1.19B$164.63M$499.37M$310.37M-$58.21M
    Cash from Financing$24.98M$449.24M$529.47M$100.33M$34.76M$7.48M$4.39M$3.79M$242.04M
    SummaryCapital Expenditure-$8.19M-$8.94M-$6.55M-$21.82M-$68.01M-$21.57M-$7.30M-$4.83M-$1.09M
    Free Cash Flow-$102.29M-$138.57M-$197.49M-$69.41M$1.60B-$800.36M-$453.65M-$396.61M-$203.59M
    FCF Margin-958.8%-1712.7%-258.6%-6.3%98.7%-928.7%-611.4%-578.5%-67.1%

    Ratios